Skip to main content

What the FDA labels say about taking them together

Desloratadine and loratadine

Desloratadine's FDA label of May 17, 2025 names loratadine in its contraindications section; the loratadine label PlainMeds reads does not name desloratadine. The desloratadine label: “CONTRAINDICATIONS CLARINEX Tablets, RediTabs, and Oral Solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine.”

Check it at the source: the desloratadine FDA label on DailyMed (effective May 17, 2025, Organon LLC); the loratadine FDA label on DailyMed (effective December 5, 2025, Bayer HealthCare LLC.).

What does the desloratadine label say about loratadine?

Desloratadine label, contraindications

CONTRAINDICATIONS CLARINEX Tablets, RediTabs, and Oral Solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see Warnings and Precautions (5.1) and Adverse Reactions (6.2) ].

Source: FDA drug label (Clarinex), Organon LLC, effective May 17, 2025 (SPL set c671342e-69a2-4ca5-abc2-8166ed4240d4), via openFDA; the full label on DailyMed

What does the loratadine label say about desloratadine?

Loratadine's label (effective December 5, 2025) does not name desloratadine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Claritin), Bayer HealthCare LLC., effective December 5, 2025 (SPL set 660ac9df-f1b1-4c89-94dd-9fae0a013f3c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Desloratadine generic labelers
149Loratadine generic labelers
DesloratadineLoratadine
Labeled forAllergiesn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.258 per tablet 5 mg tablet$0.0529 per tablet 10 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?